In September 2017, Munich will once again provide the stage for international top leaders in the field of diabetes:


The 5th high-impact

Helmholtz-Nature Medicine Diabetes Conference

will take place!


Certainly, it's already a fixed date on your calendar. So don't miss the early bird booking and learn more about this year's focus, outstanding stars and its special atmosphere in 2017.

Several regularly appearing announcements like this one via twitter and facebook will provide you with important information about speakers, topics, the conference program and accompanying social events.

So keep checking your social media accounts and follow
Helmholtz Zentrum München!

Concept and contents by Sonja Duggen

Any suggestions or questions? Tweet us @helmholtzMucEn

Additional information at: #HelmholtzDiabetes2017


Every year, this conference series integrates research reports on essential scientific questions in urgent need of a breakthrough.

In 2017, researchers of renowned research groups along with selected young stars will come together to focus on continuing and emerging "hot" research topic areas including: 


  • the molecular basis of exercise benefits

  • beta-cell regeneration

  • adipocyte biology

  • novel links connecting cellular energy metabolism with aging

The Organizers

The Helmholtz-Nature Medicine Diabetes Conference is a cooperation between Helmholtz Zentrum München and Nature Medicine. Its increasing popularity reflects the unique outcome in terms of scientific collaborations which propels diabetes research to another level and drives new approaches for improving the treatment of this challenging disease. 

Every year, the organizers Matthias Tschöp and Randy Levinson try something new. The concept of a changing co-organizer is one important driver for this innovation. This person always gives the conference a special flavor and distinction: The co-organizer not only searches for currently important topics for the scientific program, but also for young upcoming researchers next to highly recognized speakers to present their latest findings.

This year, Susanna Hofmann from Helmholtz Zentrum München will help to make this conference another successful event with new insights into diabetes research, new collaborations and an inspiring atmosphere where everyone dares to ask questions and shares – even unpublished – results! 

Previous Co-Organizers:



Prof. Dr. Matthias Tschöp, Institute for Diabetes and Obesity at Helmholtz Zentrum München, and head of the Department of Metabolic Diseases at Technische Universität München, is scientific director of the Helmholtz Diabetes Center.

Institute for Diabetes and Obesity

Matthias Tschöp – Organizer

"Obviously, the privilege and experience to organize the first four conferences helped to refine and optimize our innovative concept. But there is always that excitement of how this year's theme and specific panel of international speakers will generate that vibe of a cutting edge research networking platform which has gained our conference considerable international recognition in such a short time. We could not be more excited about the unexpectedly rapid progress we have already made and have the feeling that this year's symposium will give us even larger momentum toward effectively crosslinking research worldwide to cure diabetes once and for all."

Academic Positions and Career

Matthias Tschöp is the first German physician to receive the Alexander von Humboldt Professorship, the highest-endowed German research award (2012). He is Research Director of the Helmholtz Diabetes Center and Director of the Institute for Diabetes and Obesity. He holds the Chair of the Division of Metabolic Diseases at Technische Universität München. He is Adjunct Professor at Yale University. Furthermore, he is Founding Editor-in-Chief of the journal Molecular Metabolism. Prof. Tschöp received his M.D. from Ludwig-Maximilians-Universität in Munich. In 1999 he accepted an invitation for a postdoctoral fellowship at the Eli Lilly Research Laboratories in the U.S. After establishing his independent research laboratory at the German Institute of Human Nutrition Potsdam-Rehbrücke in Germany in 2002 and 2003, he returned to Cincinnati where he led a research institute as a tenured Professor of Endocrinology and Diabetes at the University of Cincinnati Metabolic Diseases Institute. Until 2009, Prof. Tschöp was the Arthur Russell Morgan Endowed Chair of Medicine and Research Director of the University of Cincinnati’s Metabolism Center of Excellence for Diabetes and Obesity.


Prof. Tschöp’s research focuses on dissecting the molecular underpinnings of diabetes and obesity in order to discover new preventive and therapeutic approaches for the metabolic syndrome. One of his areas of interest is the role of gut-brain communication as a key circuitry that regulates adiposity, glucose homeostasis and energy metabolism. Currently, the IDO team is aiming to develop innovative interdisciplinary approaches in collaboration with physicists, engineers and chemists for the personalized prevention and treatment of obesity, diabetes and concomitant diseases.

Matthias Tschöp represents a unique blend of experience in clinical endocrinology (resident physician at Munich University Hospital, 1993-1998), drug discovery (postdoctoral fellow at Eli Lilly and Company Endocrine Research, 1999-2002) and basic/translational hormone research (principal investigator since 2002). He is well recognized for his work on how gut-brain communication regulates appetite and metabolism and for combining groundbreaking discovery with translational potential.

Academic Service

Matthias Tschöp has organized numerous academic conferences, including Keystone Symposia, EMBL Symposia, such as, currently, the EMBO/EMBL Symposium "Translating Diabetes."  In 2013 he started the Annual Helmholtz-Nature Medicine Diabetes Conference. The 5th Annual Helmholtz-Nature Medicine Diabetes Conference will take place in September 2017. He currently directs several research networks including the Helmholtz Alliance ICEMED. 

Much sought after as an international lecturer and active reviewer and referee for scientific journals such as Nature, Science and Cell. Prof. Tschöp also maintains international collaborations with the Rockefeller Center, Yale University, Harvard Medical School and Cambridge University, among others. Throughout his career, Professor Tschöp has worked closely with several major pharmaceutical and numerous biotechnology companies in the field of diabetes, obesity and cardiovascular disease and has served as consultant on several scientific advisory boards.

Awards and Recognitions – a Selection

2017: Charles H. Best Lectureship and Award, University of Toronto
2017: Honorary doctorate (Dr. h.c.), University of Leipzig
2017: Rolf Sammet Guest Professorship at Frankfurt University
2017: Geoffrey Harris Prize
2017: Endocrine Society Outstanding Innovation Award
2016: Elected Member, Academia Europaea
2016: ERC Advanced Grant
2014: Flam Erwin Schrödinger Prize
Paul Martini Prize, Paul Martini Foundation
2014: Linda and Jack Gill Distinguished Scientist Award, Linda and Jack Gill Center for Biomolecular Science at Indiana University
2013: Elected member of the German National Academy of Science (Leopoldina)
2013: Elected member of the Helmholtz Think Tank, Helmholtz Association
2012: Werner Creutzfeld Award, German Diabetes Association
2011: Alexander von Humboldt Professorship
2011: Outstanding Scientific Achievement Award, American Diabetes Association
2010: NIH/NIDDK 60th Anniversary Scholar Award
2010: André Mayer Award, Int. Association for the Study of Obesity (IASO)
2007: Scientific Achievement Award, The Obesity Society (TOS/NAASO)

Prof. Dr. Susanna Hofmann, Institute of Diabetes and Regeneration Research at Helmholtz Zentrum München, and head of the group "Women and Diabetes".

Women and Diabetes

Susanna Hofmann – Co-Organizer

"Regular physical exercise not only reduces the risk of developing metabolic diseases, such as obesity and type 2 diabetes, it also has beneficial effects on their complications like lowering blood pressure and improving lipid levels and cardiovascular disease. In this year’s conference we will put a spotlight on the molecular basis for the important exercise-induced adaptations leading to its profound health benefits."

Academic Positions and Career

Susanna Hofmann has been head of the research unit "Women and Diabetes – Gender Research in Diabetes" of the Institute of Diabetes and Regeneration Research at Helmholtz Zentrum München since 2011. In 2014 she received the W2 professorship in Lipid Metabolism at Ludwig Maximilians Universität München, Germany.

Before this, Hofmann held positions in the U.S.: From 2009-2011 she was research assistant professor in the Division of Endocrinology at the Department of Internal Medicine at the University of Cincinnati, College of Medicine. From 2005-2009 Hofmann was faculty member and instructor at the Department of Pathology at the University of Cincinnati, College of Medicine. From 2000-2005 she was postdoctoral fellow at Mount Sinai School of Medicine and at Albert Einstein College of Medicine in New York and at the University of Cincinnati.

Academic Service

Susanna Hofmann has expertise in teaching and organizing seminars, as well as in editing and consulting. She maintains international collaborations with Yale University, UCLA, University of Denver, NYU and the LIKES Research Centre for Physical Activity and Health.


Susanna Hofmann's research activities focus on the molecular mechanisms causing gender and sex specific differences in diabetic dyslipidemia. She tries to identify novel ways for treatment and to simultaneously target all major components of the metabolic syndrome. She also investigates the potential mechanisms of exercise-induced improvements on diabetic dyslipidemia and wants to determine how lipoproteins influence cellular function in specific cell populations of skeletal muscle, gut, brain and adipose tissue.

Prizes and Awards:

2011: Finalist (3rd) of the Irvine H. Page Young Investigator Research Award by the Society for
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
2010: BIRCWH Research Scholar Award by the National Institute for Health (NIH) Office of Research on
Women’s Health (ORWH).
2006: Scientist Development Award by the American Heart Association (AHA)
2007: Young Investigator Travel Award by the Society for Arteriosclerosis, Thrombosis and Vascular
Biology (ATVB)
2006: NIDDK Keystone Symposium Scholarship Award by the National Institute for Diabetes, Digestive
and Kidney Disease (NIDDK)
2002: Albert Renold Fellowship Award by the European Association for the Study of Diabetes (EASD)
2000: Emmy Noether Career Development Award by the German Research Council (DFG)
2002: Travel Award, Annual Meeting of the German Diabetes Society (DDG)
2002: NIDDK Keystone Symposium Scholarship Award
2001: President’s Poster, 61st Scientific Sessions of the American Diabetes Association (ADA)
2000: Travel Award, 36th Annual Meeting, European Association for the Study of Diabetes (EASD)
1997: Award for Best Poster, Italian Arterial Hypertension Association Annual Meeting

Dr. Randy Levinson

As an undergraduate student at Caltech, Randy Levinson studied the evolution and the proteolytic regulation of alphavirus replication in the lab of James Strauss. He went on to graduate school in Keith Yamamoto's lab at the University of California, San Francisco, to study the regulation of nuclear hormone receptor signaling using a yeast genetic screen. After graduation, he carried out postdoctoral work with Eseng Lai at Memorial Sloan-Kettering Cancer Center, where he investigated the role of renal stroma in embryonic kidney development. He continued these studies during a second postdoc at Columbia University with Cathy Mendelsohn before joining Nature Medicine in 2005.

Randy Levinson 

Every year, Randy Levinson along with Matthias Tschöp puts together the program of the Helmholtz-Nature Medicine Diabetes Conference. Randy Levinson is senior editor of the scientific journal Nature Medicine Diabetes since 2005. Prior to this he studied biology in the USA. 

The familiar atmosphere at the conference gets Friedman to share his latest data.


"Our colleagues from around the world decide every year to show unpublished, new data – and that's what makes this conference so exciting!"  Matthias Tschöp

Jeffrey M. Friedman, Marilyn M. Simpson Professor, Rockefeller University, New York.

Be Part of the World's Leading Diabetes Community

Join this inspiring atmosphere and learn about new diabetes discoveries that will propel you to another level of research.

Early bird registration is open. Regular booking starts on July 1, 2017.

For booking and all information about conditions and offers please follow the link below:


Location and Accommodation

You will be in Munich during the "fifth season". This means that you will be in the city when it holds the biggest public festival worldwide: The Oktoberfest!

Please note that, during this time the world is at home in Munich, and therefore hotel rooms are limited.

We help by offering a fixed contingent in some hotels. Take advantage of this offer and book your accommodation through the registration process.



The event venue, Lenbach Palais is located in a historical 19th century palace. It is one of the few buildings in central Munich that was not destroyed in the Second World War, and its original architecture, including elegant marble floors and stucco ceilings, is still intact.

The Lenbach Palais in the heart of Munich offers a unique stage for this conference: A large lecture hall and several separate areas provide space for talks and discussions in a private atmosphere. Of course, free wifi is available. 

Lenbach Palais

Lenbach Palais
Ottostraße 6
80333 Munich
Phone: +49 89 549 1300



The Lenbach Palais is located in the center of the city and easily reached by public transportation:

U-Bahn U4 and U5, stop: Karlsplatz/Stachus (2-5 min from venue)

S-Bahn all lines, stop: Karlsplatz/Stachus (2-5 min from venue)
Tram No. 19, stop: Lenbachplatz (2-3 min from venue)
Tram No. 27, stop: Lenbachplatz (2-3 min from venue)

Any questions regarding the conference?

Ask here: Conference Contact

Learn more about the

5th Helmholtz-Nature Medicine Diabetes Conference!

You can't wait to attend this conference? We will help to bridge the time until September 17th when the stars of the diabetes scene come together in Munich: Every few weeks we will provide you with more information about this conference by sending you storytellings like this. 

Thus, we will not only give you information about the schedule. Via videos and audios we will also share private views of recognized diabetes researchers who come back every year. Furthermore, you will get insights into how social events during the conference boost trust between participants and make them all partners in research for solving the mysteries of diabetes.

The next post will focus on the conference program. Learn more about: 

  • the schedule
  • the concept of the round tables
  • the evenings

We are looking forward to updating you until the conference starts and would be delighted to hear from you on twitter – see more information under "i".  

Any suggestions or questions?

Tweet us @helmholtzMucEn